IGAM
UTHR icon

iA Global Asset Management’s United Therapeutics UTHR Stock Holding History

iA Global Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
+2,551
New +$1.44M 0.02% 299
2025
Q3 		– Sell
-298
Closed -$86K – 466
2025
Q2 		$86K Sell
298
-349
-54% -$104K ﹤0.01% 402
2025
Q1 		$199K Buy
+647
New +$222K ﹤0.01% 407
2024
Q4 		– Sell
-981
Closed -$352K – 506
2024
Q3 		$352K Buy
+981
New +$331K 0.01% 417

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

iA Global Asset Management's UTHR Position: Q2 2026 in Review

iA Global Asset Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,551 shares worth $1.38M. The stake represents 0.02% of the portfolio and ranks #299 among its holdings. This is a return to the name: iA Global Asset Management previously reported a position in UTHR as recently as Q2 2025.

iA Global Asset Management first reported a position in UTHR in Q3 2024 and has held it in 4 quarters since. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • iA Global Asset Management held 2,551 shares of United Therapeutics worth $1.38M as of Q2 2026.
  • United Therapeutics was a new iA Global Asset Management position in Q2 2026.
  • United Therapeutics made up 0.02% of iA Global Asset Management's portfolio in Q2 2026, its #299 holding.
  • iA Global Asset Management first reported a position in United Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.